Long-Term Treatment With Mavacamten and Improved Left Atrial Strain in Obstructive Hypertrophic Cardiomyopathy

被引：0
|
作者：
Lee, Hyun-Jung [1 ]
Hong, Geu-Ru [1 ]
机构：
[1] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, 50-1 Yonsei Ro, Seoul 03722, South Korea
来源：
JACC-CARDIOVASCULAR IMAGING | 2025年 / 18卷 / 03期
关键词：
hypertrophic cardiomyopathy; left atrial strain; mavacamten; myocardial deformation; myosin inhibitor; MYECTOMY;
D O I：
10.1016/j.jcmg.2024.09.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：263 / 265
页数：3
相关论文
共 50 条
  • [41] Evaluating the Sustained Benefits of Mavacamten in Patients with Obstructive Hypertrophic Cardiomyopathy (oHCM) "Long-term AI-ECG and Echocardiographic Data"
    Suppah, Mustafa
    Roehl, Kaitlin
    Adalla, Hesham
    Ferina, Juan
    Arsanjani, Reza
    Alsidawi, Said
    JOURNAL OF CARDIAC FAILURE, 2024, 30 : S10 - S10
  • [42] LONG-TERM OUTCOME IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY AFTER SURGERY
    BOURMAYAN, C
    LEVY, S
    DESNOS, M
    CRISTOFINI, P
    ATTAL, B
    GAY, J
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : A230 - A230
  • [43] Long-term outcomes of septal reduction for obstructive hypertrophic cardiomyopathy
    Sedehi, Daniel
    Finocchiaro, Gherardo
    Tibayan, Yen
    Chi, Jeffrey
    Pavlovic, Aleksandra
    Kim, Young M.
    Tibayan, Frederick A.
    Reitz, Bruce A.
    Robbins, Robert C.
    Woo, Joseph
    Ha, Richard
    Lee, David P.
    Ashley, Euan A.
    JOURNAL OF CARDIOLOGY, 2015, 66 (1-2) : 57 - 62
  • [44] LONG-TERM MEDICAL-MANAGEMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    FRANK, MJ
    ABDULLA, AM
    CANEDO, MI
    AMERICAN JOURNAL OF CARDIOLOGY, 1977, 39 (02): : 271 - 271
  • [45] LONG-TERM MEDICAL-MANAGEMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    FRANK, MJ
    ABDULLA, AM
    CANEDO, MI
    SAYLORS, RE
    AMERICAN JOURNAL OF CARDIOLOGY, 1978, 42 (06): : 993 - 1001
  • [46] Mavacamten: treatment aspirations in hypertrophic cardiomyopathy
    Papadakis, Michael
    Basu, Joyee
    Sharma, Sanjay
    LANCET, 2020, 396 (10253): : 736 - 737
  • [47] Long-Term Prognosis after Myectomy in Hypertrophic Obstructive Cardiomyopathy with Severe Left Ventricular Hypertrophy
    An, Shuoyan
    Fan, Chaomei
    Yang, Yinjian
    Hang, Fei
    Wang, Zhimin
    Zhang, Yuhui
    Zhang, Jian
    CARDIOLOGY, 2018, 139 (02) : 83 - 89
  • [48] Incidence of newly recognized atrial fibrillation in patients with obstructive hypertrophic cardiomyopathy treated with Mavacamten
    Castrichini, Matteo
    Alsidawi, Said
    Geske, Jeffrey B.
    Newman, Darrell B.
    Arruda-Olson, Adelaide M.
    Bos, J. Martijn
    Ommen, Steve R.
    Siontis, Konstantinos C.
    Ackerman, Michael J.
    Giudicessi, John R.
    HEART RHYTHM, 2024, 21 (10) : 2065 - 2067
  • [49] Genotype Influences Mavacamten Responsiveness in Obstructive Hypertrophic Cardiomyopathy
    Giudicessi, John R.
    Alsidawi, Said
    Geske, Jeffrey B.
    Newman, Darrell B.
    Arruda-Olson, Adelaide M.
    Bos, j. Martijn
    Ommen, Steve R.
    Ackerman, Michael J.
    MAYO CLINIC PROCEEDINGS, 2024, 99 (02) : 341 - 343
  • [50] Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy
    Zampieri, Mattia
    Argiro, Alessia
    Marchi, Alberto
    Berteotti, Martina
    Targetti, Mattia
    Fornaro, Alessandra
    Tomberli, Alessia
    Stefano, Pierluigi
    Marchionni, Niccolo
    Olivotto, Iacopo
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
12345